Recombinant Human NCBP1 Protein, N-His

Introduction

Recombinant Human NCBP1 protein, also known as Nuclear Cap-Binding Protein Subunit 1, is a key component of the nuclear cap-binding complex (CBC) that is involved in various cellular processes such as mRNA processing, transport, and translation. This protein is highly conserved among eukaryotes and plays a crucial role in maintaining the integrity and stability of the mRNA cap structure. In this article, we will discuss the structure, activity, and applications of Recombinant Human NCBP1 Protein.

Structure of Recombinant Human NCBP1 Protein

Recombinant Human NCBP1 Protein is a 55 kDa protein that consists of 490 amino acids. It contains a conserved N-terminal domain that is responsible for binding to the cap structure of mRNA and a C-terminal domain that interacts with other components of the CBC complex. The crystal structure of NCBP1 has been determined and it reveals a three-domain architecture with the N-terminal domain forming a β-barrel structure and the C-terminal domain forming an α-helical structure.

Activity of Recombinant Human NCBP1 Protein

The main activity of Recombinant Human NCBP1 Protein is its role in mRNA processing and transport. It binds to the 5′ cap structure of mRNA and protects it from degradation by exonucleases. NCBP1 also plays a crucial role in the splicing and polyadenylation of mRNA. It interacts with other components of the CBC complex to facilitate the export of mature mRNA from the nucleus to the cytoplasm. In addition, NCBP1 has been shown to play a role in translation initiation by interacting with eukaryotic translation initiation factor 4E (eIF4E) and promoting the recruitment of ribosomes to the mRNA.

Applications of Recombinant Human NCBP1 Protein

Recombinant Human NCBP1 Protein has a wide range of applications in both basic research and biotechnology. Some of the key applications include:

• Studying mRNA processing and transport: NCBP1 is a critical component of the CBC complex, which is involved in various stages of mRNA processing and transport. Recombinant NCBP1 can be used to study the role of this protein in these processes.
• Investigating the role of NCBP1 in translation initiation: NCBP1 has been shown to interact with eIF4E and play a role in translation initiation. Recombinant NCBP1 can be used to investigate the molecular mechanisms of this interaction and its impact on translation.
• Development of vaccines: Recombinant NCBP1 has been used as an antigen in vaccine development against viral infections. It has been shown to induce a strong immune response and can be used as a potential target for vaccine development.
• Production of therapeutic proteins: NCBP1 has been used as a fusion partner for the production of therapeutic proteins in mammalian cells. The N-terminal domain of NCBP1 can be used to target the protein to the nucleus, while the C-terminal domain can facilitate its export to the cytoplasm, resulting in higher yields of the desired protein.

Conclusion

Recombinant Human NCBP1 Protein is a crucial component of the nuclear cap-binding complex and plays a key role in mRNA processing, transport, and translation. Its structure and activity have been extensively studied, and it has various applications in basic research and biotechnology. As our understanding of the role of NCBP1 in cellular processes continues to grow, the potential for its use in various fields will also increase.